FR2451194A1 - Nouveau medicament a base de ganglioside notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant - Google Patents
Nouveau medicament a base de ganglioside notamment pour le traitement du cholera, et compositions pharmaceutiques le contenantInfo
- Publication number
- FR2451194A1 FR2451194A1 FR7906732A FR7906732A FR2451194A1 FR 2451194 A1 FR2451194 A1 FR 2451194A1 FR 7906732 A FR7906732 A FR 7906732A FR 7906732 A FR7906732 A FR 7906732A FR 2451194 A1 FR2451194 A1 FR 2451194A1
- Authority
- FR
- France
- Prior art keywords
- esp
- moles
- ganglioside
- diarrhoea
- contg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
NOUVEAU MEDICAMENT ET COMPOSITIONS PHARMACEUTIQUES LE CONTENANT. CE MEDICAMENT EST CARACTERISE PAR LE FAIT QU'IL EST CONSTITUE PAR UN SUPPORT SUR LEQUEL EST FIXE UN GANGLIOSIDE OU UN DERIVE DE GANGLIOSIDE DOUE D'AFFINITE POUR LES TOXINES PRODUITES PAR DES BACTERIES RESPONSABLES DES DIARRHEES, ET NOTAMMENT POUR LA TOXINE CHOLERIQUE. APPLICATION AU TRAITEMENT PREVENTIF OU CURATIF DES DIARRHEES AIGUES ET NOTAMMENT DU CHOLERA.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7906732A FR2451194A1 (fr) | 1979-03-16 | 1979-03-16 | Nouveau medicament a base de ganglioside notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant |
PCT/FR1980/000037 WO1980001875A1 (fr) | 1979-03-16 | 1980-03-17 | Nouveau medicament, notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant |
US06/217,114 US4347244A (en) | 1979-03-16 | 1980-03-17 | Ganglioside containing compositions for treating diarrhea |
EP80400353A EP0016702B1 (fr) | 1979-03-16 | 1980-03-17 | Médicament, notamment pour le traitement du choléra, et compositions pharmaceutiques le contenant |
DE8080400353T DE3070189D1 (en) | 1979-03-16 | 1980-03-17 | Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it |
JP50067380A JPS56500138A (fr) | 1979-03-16 | 1980-03-17 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7906732A FR2451194A1 (fr) | 1979-03-16 | 1979-03-16 | Nouveau medicament a base de ganglioside notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2451194A1 true FR2451194A1 (fr) | 1980-10-10 |
FR2451194B1 FR2451194B1 (fr) | 1983-11-10 |
Family
ID=9223206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7906732A Granted FR2451194A1 (fr) | 1979-03-16 | 1979-03-16 | Nouveau medicament a base de ganglioside notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2451194A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0036372A1 (fr) * | 1980-03-17 | 1981-09-23 | Institut Merieux | Nouveaux dérivés de gangliosides, leur préparation et leur application |
EP0097059A2 (fr) * | 1982-06-16 | 1983-12-28 | Unilever N.V. | Compositions pour le traitement de la peau |
WO2006125496A2 (fr) * | 2005-05-26 | 2006-11-30 | Flamma S.P.A. | Formulations pharmaceutiques renfermant des principes actifs pharmaceutiques absorbes sur des nanoparticules de dioxyde de titane |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2319399A1 (fr) * | 1975-07-29 | 1977-02-25 | Merieux Inst | Nouveau materiau a caractere cationique, capable de fixer de facon reversible, des macromolecules biologiques, procedes de preparation et applications |
FR2320760A1 (fr) * | 1975-08-13 | 1977-03-11 | Fidia Spa | Utilisation therapeutique nouvelle des gangliosides et procede pour leur extraction |
-
1979
- 1979-03-16 FR FR7906732A patent/FR2451194A1/fr active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2319399A1 (fr) * | 1975-07-29 | 1977-02-25 | Merieux Inst | Nouveau materiau a caractere cationique, capable de fixer de facon reversible, des macromolecules biologiques, procedes de preparation et applications |
FR2320760A1 (fr) * | 1975-08-13 | 1977-03-11 | Fidia Spa | Utilisation therapeutique nouvelle des gangliosides et procede pour leur extraction |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0036372A1 (fr) * | 1980-03-17 | 1981-09-23 | Institut Merieux | Nouveaux dérivés de gangliosides, leur préparation et leur application |
EP0097059A2 (fr) * | 1982-06-16 | 1983-12-28 | Unilever N.V. | Compositions pour le traitement de la peau |
EP0097059A3 (en) * | 1982-06-16 | 1985-07-10 | Unilever Nv | Skin treatment compositions |
WO2006125496A2 (fr) * | 2005-05-26 | 2006-11-30 | Flamma S.P.A. | Formulations pharmaceutiques renfermant des principes actifs pharmaceutiques absorbes sur des nanoparticules de dioxyde de titane |
WO2006125496A3 (fr) * | 2005-05-26 | 2007-04-12 | Flamma Spa | Formulations pharmaceutiques renfermant des principes actifs pharmaceutiques absorbes sur des nanoparticules de dioxyde de titane |
Also Published As
Publication number | Publication date |
---|---|
FR2451194B1 (fr) | 1983-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4347244A (en) | Ganglioside containing compositions for treating diarrhea | |
PH23256A (en) | A process for the preparation of quinolone carboxylic acid derivatives | |
HU895388D0 (en) | Process for preparation of 4-demethoxy-anthracyclinones | |
FI885464A (fi) | Asyylioksiasyylihydrolaasi ja sen käyttö | |
ZA887641B (en) | Polysulfuric acid esters of bis-aldonamides and their derivatives,process for their preparation and medicaments | |
DE3662041D1 (en) | New carboxylic acid derivatives, their manufacturing process, use and medicines containing these compounds | |
ZA889699B (en) | Use of polysulfated heparins | |
AU617318B2 (en) | Outer membrane protein f of pseudomonas aeruginosa | |
FR2451194A1 (fr) | Nouveau medicament a base de ganglioside notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant | |
Dajani et al. | Experimental infection of the skin in the hamster simulating human impetigo: II. Assessment of various therapeutic regimens | |
HUT47581A (en) | Process for production of calium-salt of one piranquinilin dicarbonic acid and medical compositions containing them | |
PT79712A (fr) | Procede de preparation de compositions nutritives contenant de l'acide alpha-cetoisocaproique ou un de ses sels et de medicaments les contenant | |
JPS579725A (en) | Method of promoting oral absorption of glycoside and related antibiotics | |
GR3008746T3 (fr) | ||
Seeberg et al. | Calcium carbonate as an antacid for oral penicillin | |
FR2425438A1 (fr) | Nouveaux derives d'acide ((o-(dithiolanne-1,3 imino-2) substitue)-2 acetyl-amino)-7 cephalosporanique, leur procede de preparation et leur utilisation comme medicaments antibacteriens | |
FR2607392B1 (fr) | Procede pour la preparation d'une souche mutante de bordetella bronchiseptica utile pour la preparation d'un vaccin vivant attenue pour la prophylaxie des infections a b. bronchiseptica et vaccin vivant attenue contre la rhinite atrophique ainsi prepare | |
JPS5550890A (en) | Preparation of n-acylneuraminic acid aldolase | |
SU1541218A1 (ru) | Способ получения производных декстрана | |
Vasilevskaya et al. | Desalted water- Source of microorganism contamination of noninjected medicines. | |
GB837993A (en) | A process for the preparation of levans | |
DE2910509A1 (de) | Teilchenfoermiges material fuer medizinische zwecke, verfahren zu seiner herstellung und seine verwendung als arzneimittel | |
FR2163363A1 (en) | L-asparaginase purification - by t-butanol precipitation from aqs solns | |
BG49408A1 (en) | Medicationad premix | |
TH7959EX (th) | กรรมวิธีสำหรับการผลิตแอล-ธรีโอไนน์ ด้วยการหมัก |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |